BAM
GMAB icon

Blueshift Asset Management’s Genmab GMAB Stock Holding History

Blueshift Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,776
Closed -$426K – 799
2022
Q1 		$426K Buy
+11,776
New +$404K 0.04% 491
2021
Q4 		– Sell
-12,911
Closed -$564K – 999
2021
Q3 		$564K Buy
+12,911
New +$580K 0.03% 583

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Blueshift Asset Management's GMAB Position: Q2 2022 in Review

Blueshift Asset Management sold out of Genmab (GMAB) in Q2 2022, closing a stake of 11,776 shares — an estimated $426K sold.

Blueshift Asset Management first reported a position in GMAB in Q3 2021 and held it in 2 quarters. The position peaked at $564K in Q3 2021. 180 funds tracked by Wall St. Rank hold GMAB as of Q2 2022.

  • Blueshift Asset Management reported no remaining Genmab position as of Q2 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 11,776 Genmab shares in Q2 2022, an estimated $426K.
  • Blueshift Asset Management first reported a position in Genmab in Q3 2021 and held it in 2 quarters.
  • Blueshift Asset Management's Genmab position peaked at $564K in Q3 2021.
  • 180 funds tracked by Wall St. Rank held Genmab as of Q2 2022.

Based on Blueshift Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.